129 related articles for article (PubMed ID: 32908433)
41. Effects of serum and insulin-like growth factor I on protein degradation and protease gene expression in rat L8 myotubes.
Hong D; Forsberg NE
J Anim Sci; 1994 Sep; 72(9):2279-88. PubMed ID: 8002447
[TBL] [Abstract][Full Text] [Related]
42. Bacterial lipopolysaccharide induces rainbow trout myotube atrophy via Akt/FoxO1/Atrogin-1 signaling pathway.
Aedo JE; Reyes AE; Avendaño-Herrera R; Molina A; Valdés JA
Acta Biochim Biophys Sin (Shanghai); 2015 Nov; 47(11):932-7. PubMed ID: 26341977
[TBL] [Abstract][Full Text] [Related]
43. AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells.
Krawiec BJ; Nystrom GJ; Frost RA; Jefferson LS; Lang CH
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1555-67. PubMed ID: 17264220
[TBL] [Abstract][Full Text] [Related]
44. A dynamic ribosomal biogenesis response is not required for IGF-1-mediated hypertrophy of human primary myotubes.
Crossland H; Timmons JA; Atherton PJ
FASEB J; 2017 Dec; 31(12):5196-5207. PubMed ID: 28774889
[TBL] [Abstract][Full Text] [Related]
45. The Effect of Mechanical Stretch on Myotube Growth Suppression by Colon-26 Tumor-Derived Factors.
Halle JL; Counts-Franch BR; Prince RM; Carson JA
Front Cell Dev Biol; 2021; 9():690452. PubMed ID: 34395422
[TBL] [Abstract][Full Text] [Related]
46. L-leucine, beta-hydroxy-beta-methylbutyric acid (HMB) and creatine monohydrate prevent myostatin-induced Akirin-1/Mighty mRNA down-regulation and myotube atrophy.
Mobley CB; Fox CD; Ferguson BS; Amin RH; Dalbo VJ; Baier S; Rathmacher JA; Wilson JM; Roberts MD
J Int Soc Sports Nutr; 2014; 11():38. PubMed ID: 25132809
[TBL] [Abstract][Full Text] [Related]
47. IL-13 mediates the recruitment of reserve cells for fusion during IGF-1-induced hypertrophy of human myotubes.
Jacquemin V; Butler-Browne GS; Furling D; Mouly V
J Cell Sci; 2007 Feb; 120(Pt 4):670-81. PubMed ID: 17264150
[TBL] [Abstract][Full Text] [Related]
48. Involvement of released sphingosine 1-phosphate/sphingosine 1-phosphate receptor axis in skeletal muscle atrophy.
Pierucci F; Frati A; Battistini C; Matteini F; Iachini MC; Vestri A; Penna F; Costelli P; Meacci E
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3598-3614. PubMed ID: 30279138
[TBL] [Abstract][Full Text] [Related]
49. Chronic Exercise Training Down-Regulates TNF-α and Atrogin-1/MAFbx in Mouse Gastrocnemius Muscle Atrophy Induced by Hindlimb Unloading.
Al-Nassan S; Fujita N; Kondo H; Murakami S; Fujino H
Acta Histochem Cytochem; 2012 Dec; 45(6):343-9. PubMed ID: 23378678
[TBL] [Abstract][Full Text] [Related]
50. Testosterone represses ubiquitin ligases atrogin-1 and Murf-1 expression in an androgen-sensitive rat skeletal muscle in vivo.
Pires-Oliveira M; Maragno AL; Parreiras-e-Silva LT; Chiavegatti T; Gomes MD; Godinho RO
J Appl Physiol (1985); 2010 Feb; 108(2):266-73. PubMed ID: 19926828
[TBL] [Abstract][Full Text] [Related]
51. Interaction of insulin-like growth factor I with turkey satellite cells and satellite cell-derived myotubes.
Minshall RD; McFarland DC; Doumit ME
Domest Anim Endocrinol; 1990 Jul; 7(3):413-24. PubMed ID: 2167814
[TBL] [Abstract][Full Text] [Related]
52. Excessive glucocorticoid-induced muscle MuRF1 overexpression is independent of Akt/FoXO1 pathway.
Wang XJ; Xiao JJ; Liu L; Jiao HC; Lin H
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046370
[TBL] [Abstract][Full Text] [Related]
53. Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients.
Léger B; Senese R; Al-Khodairy AW; Dériaz O; Gobelet C; Giacobino JP; Russell AP
Muscle Nerve; 2009 Jul; 40(1):69-78. PubMed ID: 19533653
[TBL] [Abstract][Full Text] [Related]
54. IGF-1 prevents simvastatin-induced myotoxicity in C2C12 myotubes.
Bonifacio A; Sanvee GM; Brecht K; Kratschmar DV; Odermatt A; Bouitbir J; Krähenbühl S
Arch Toxicol; 2017 May; 91(5):2223-2234. PubMed ID: 27734117
[TBL] [Abstract][Full Text] [Related]
55. Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction.
Schulze PC; Fang J; Kassik KA; Gannon J; Cupesi M; MacGillivray C; Lee RT; Rosenthal N
Circ Res; 2005 Sep; 97(5):418-26. PubMed ID: 16051886
[TBL] [Abstract][Full Text] [Related]
56. Conditional activation of MET in differentiated skeletal muscle induces atrophy.
Crepaldi T; Bersani F; Scuoppo C; Accornero P; Prunotto C; Taulli R; Forni PE; Leo C; Chiarle R; Griffiths J; Glass DJ; Ponzetto C
J Biol Chem; 2007 Mar; 282(9):6812-22. PubMed ID: 17194700
[TBL] [Abstract][Full Text] [Related]
57. Effects of combined hormone replacement therapy or its effective agents on the IGF-1 pathway in skeletal muscle.
Pöllänen E; Ronkainen PH; Horttanainen M; Takala T; Puolakka J; Suominen H; Sipilä S; Kovanen V
Growth Horm IGF Res; 2010 Oct; 20(5):372-9. PubMed ID: 20724185
[TBL] [Abstract][Full Text] [Related]
58. Insulin and amino acid availability regulate atrogin-1 in avian QT6 cells.
Tesseraud S; Métayer-Coustard S; Boussaid S; Crochet S; Audouin E; Derouet M; Seiliez I
Biochem Biophys Res Commun; 2007 May; 357(1):181-6. PubMed ID: 17418104
[TBL] [Abstract][Full Text] [Related]
59. Regulatory factors controlling muscle mass: Competition between innate immune function and anabolic signals in regulation of atrogin-1 in Atlantic salmon.
Heidari Z; Bickerdike R; Tinsley J; Zou J; Wang TY; Chen TY; Martin SA
Mol Immunol; 2015 Oct; 67(2 Pt B):341-9. PubMed ID: 26184653
[TBL] [Abstract][Full Text] [Related]
60. 1α,25(OH)2D3 downregulates gene expression levels of muscle ubiquitin ligases MAFbx and MuRF1 in human myotubes.
Hayakawa N; Fukumura J; Yasuno H; Fujimoto-Ouchi K; Kitamura H
Biomed Res; 2015; 36(2):71-80. PubMed ID: 25876656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]